Efficacy of Eflornithine Hydrochloride Cream in the Treatment of Melasma: A Randomized, Double-blinded, Split-face Controlled Study

Randomised Double-blinded Split-face Controlled Study to Evaluate the Effectiveness of Eflornithine Hydrochloride Cream Compared to Topical Hydroquinone 2% Cream for the Treatment of Melasma.

The goal of this clinical trial is to learn if Eflornithine hydrochloride cream works to treat melasma in adults, in comparison to Hydroquinone cream. It will also learn about the safety of Eflornithine hydrochloride cream. The main questions it aims to answer are:

• Does Eflornithine hydrochloride improve melasma assessment scores over a 3-month duration compared to Hydroquinone cream?
• What side effects might patients get while using Eflornithine hydrochloride cream?

Participants will:

• Apply both Eflornithine hydrochloride and Hydroquinone creams on separate halves of their faces every day for 3 months.
• Visit the clinic once at the 2-month mark and once at the 3-month mark for checkups and tests.

Inclusion Criteria:

• Clinical diagnosis of melasma
• Fitzpatrick Type III or IV
• Able to provide informed consent

Exclusion Criteria:

• Pregnant or lactating patients
• Patients with difficulty adhering to regular topical treatments
• Patients with known contact allergies to any of the ingredients in the topical medications used in the study